Reduction of iron overload in thalassemia.
D000293:Adolescent; D000328:Adult; D000375:Aging; D000818:Animals; D002469:Cell Separation; D002648:Child; D002675:Child, Preschool; D003676:Deferoxamine / Q000008:administration & dosage / Q000627:therapeutic use; D004905:Erythrocyte Aging; D017707:Erythrocyte Transfusion; D004912:Erythrocytes / Q000502:physiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007279:Injections, Subcutaneous; D007501:Iron / Q000097:blood / Q000652:urine; D011817:Rabbits; D012806:Siderosis / Q000209:etiology*; D013156:Splenectomy; D013789:Thalassemia / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D065227:Transfusion Reaction
D007501:Iron; D003676:Deferoxamine